I

Innoviva

D
INVA
USD
-0.24
(-1.1858%)
Market Closed
16,088.00
Volume
2.24
EPS
-
Div Yield
11.299
P/E
1,251,249,900.00
Market Cap
Today
0.3764%
1 Week
2.354%
1 Month
1.420%
6 Months
28.700%
12 Months
46.039%
Year To Date
24.844%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TGI
-0.39
(-2.4825%)
USD
A
ATGE
4.06
(4.6991%)
USD
W
WEX
-3.35
(-1.7864%)
USD
G
GKOS
-1.36
(-0.967%)
USD
A
AMRN
-0.0379
(-6.1506%)
USD
A
ATHX
0.0029
(2.9562%)
USD

Title:
Innoviva

Sector:
Healthcare
Industry:
Biotechnology
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Do you need help or have a question?
Contact Us